9 results
Lower Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Active Bleeding

#LowerExtremity #Veins #Venous #Thrombosis
- Management and ... Superficial - Active Bleeding ... #VTE #DVT #Hematology ... #Anticoagulation ... #Algorithm
Upper Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Catheter Associated

#UpperExtremity #Veins #Venous #Thrombosis
- Management and ... Anatomy Deep ... #VTE #DVT #Hematology ... #Anticoagulation ... #Algorithm
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... DVT = deep vein ... Malignancy #Cancer #Algorithm ... #Anticoagulation ... #Management #Hematology
"Management algorithm of lower extremity deep venous thrombosis. Based on the 2012 American College of Chest
"Management algorithm ... lower extremity deep ... venous thrombosis ... #DVT #Anticoagulation ... #Algorithm
Causes of Breakthrough/Extension of Thrombosis and Management Algorithm

#Anticoagulation #Breakthrough #Thrombosis #Algorithm #Extension #VTE #DVT #Hematology #Management
and Management ... Algorithm #Anticoagulation ... #Algorithm #Extension ... #VTE #DVT #Hematology ... #Management #Diagnosis
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
and incidental DVT ... catheter-related thrombosis ... without concomitant DVT ... #Anticoagulation ... #Management #Hematology
Algorithm for the diagnosis and management of iliofemoral deep vein thrombosis (DVT). In the absence of
Algorithm for the ... diagnosis and management ... of iliofemoral deep ... vein thrombosis ... catheter-directed thrombolysis
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
event, follow ACC algorithm ... Anticoagulation ... - what is the bleeding ... medical and surgical management ... stratification #diagnosis
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
MI, stroke, DVT/ ... Splenomegaly Diagnosis ... • Treatment algorithms ... Hydroxyurea + anticoagulation ... #management #hematology